Results 131 to 140 of about 216,601 (314)

L‐Relationship between uncertainty and average seizure frequency in clinical trials of antiseizure medications

open access: yesEpilepsia, EarlyView.
Abstract Objective Antiseizure medications are approved based on clinical trials that demonstrate their efficacy as measured by reductions in seizure frequency (SF). When designing these trials, trialists must select inclusion criteria where SF can be reliably measured to maintain statistical power.
Wesley T. Kerr   +6 more
wiley   +1 more source

A case of posterior reversible encephalopathy syndrome in a patient undergoing automated peritoneal dialysis [PDF]

open access: bronze, 2019
Shohei Kaneko   +14 more
openalex   +1 more source

Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis) [PDF]

open access: gold, 2011
Alex D. Greenwood   +5 more
openalex   +1 more source

Memantine treatment in individuals with GRIN gain‐of‐function variants is associated with improvements in behavior, development, and seizure frequency

open access: yesEpilepsia, EarlyView.
Abstract Objective GRIN‐related disorders due to pathogenic variants in GRIN1, GRIN2A, GRIN2B, or GRIN2D genes are associated with altered N‐methyl‐D‐aspartate receptor (NMDAR) function. Functional changes include gain (GoF) and loss of receptor function (LoF). Clinical reports describing the use of the NMDAR blocker memantine in GRIN‐related disorders
Maike Karnstedt   +17 more
wiley   +1 more source

New variants and genotype-phenotype correlation of PPP3CA-related developmental and epileptic encephalopathy [PDF]

open access: gold
Ting Wang   +9 more
openalex   +1 more source

Hepatic encephalopathy [PDF]

open access: yesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2017
openaire   +2 more sources

Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study

open access: yesEpilepsia, EarlyView.
Abstract Objective CDKL5 deficiency disorder (CDD) is a rare X‐linked developmental and epileptic encephalopathy caused by loss‐of‐function variants in the CDKL5 gene. Preclinical experiments using enzyme replacement or gene therapies show promise and could be transformative therapies.
Xavier Liogier d'Ardhuy   +8 more
wiley   +1 more source

Severe hypotension but not systemic inflammation or endothelial activation predicts encephalopathy in circulatory shock. [PDF]

open access: yesAnn Intensive Care
Nguyen DN   +9 more
europepmc   +1 more source

Rapid recovery after intrathecal dexamethasone in FIRES

open access: yes
Epileptic Disorders, EarlyView.
João Filipe Nico   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy